Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Retained Earnings (2016 - 2025)

OptimizeRx's Retained Earnings history spans 16 years, with the latest figure at -$84.3 million for Q3 2025.

  • For Q3 2025, Retained Earnings changed 0.04% year-over-year to -$84.3 million; the TTM value through Sep 2025 reached -$84.3 million, changed 0.04%, while the annual FY2024 figure was -$84.4 million, 31.3% down from the prior year.
  • Retained Earnings for Q3 2025 was -$84.3 million at OptimizeRx, up from -$85.0 million in the prior quarter.
  • Across five years, Retained Earnings topped out at -$35.3 million in Q4 2021 and bottomed at -$86.6 million in Q1 2025.
  • The 5-year median for Retained Earnings is -$57.3 million (2023), against an average of -$59.1 million.
  • The largest annual shift saw Retained Earnings grew 3.01% in 2021 before it plummeted 40.21% in 2024.
  • A 5-year view of Retained Earnings shows it stood at -$35.3 million in 2021, then crashed by 32.45% to -$46.7 million in 2022, then tumbled by 37.62% to -$64.3 million in 2023, then crashed by 31.3% to -$84.4 million in 2024, then grew by 0.13% to -$84.3 million in 2025.
  • Per Business Quant, the three most recent readings for OPRX's Retained Earnings are -$84.3 million (Q3 2025), -$85.0 million (Q2 2025), and -$86.6 million (Q1 2025).